Shenzhen University General Hospital
Shenzhen University General Hospital
Shenzhen, Other (Non U.s.), China3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of CD19-CAR.p40-T in Patients With Relapsed/Refractory CD19-Positive Hematologic Malignancies | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, acute myeloid leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, myeloid leukemia, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-05-13 | NCT07584889 | |
| Efficacy and Safety of MSLN CAR-T in Advanced Malignant Tumors | Advanced Solid Malignant Tumors (With Positive Expression of MSLN in Tumor Tissue) | Recruiting | Phase 1 / Phase 2 | 2026-02-10 | NCT07399769 | |
| Efficacy and Safety of CD19CD20-CAR.p40-T in B-cell Lymphoma | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 / Phase 2 | 2025-07-31 | NCT07097207 |